CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Understand what an index quote includes and how each component affects interpretation. This overview covers the key terms and calculations.
19,008 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Medicare’s IRMAA line can surprise retirees: income jumps today may raise premiums two years later. Experts outline h...
SpaceX is hinting at a bold new business path beyond rockets and Starlink. This article breaks down what spacex's sta...
Fortune Brands Innovations named Jesse Singh as chief executive officer and board member, installing a veteran leader...
Prime Day can bring extraordinary deals—and an uptick in fake delivery texts. This guide shows you how to spot the si...
Microsoft shares have fallen sharply this year, yet bulls argue that cloud growth and AI initiatives underpin a resil...
Sotheby’s hosts its inaugural AI-generated artwork sale, featuring the Ai-Da robot painting a portrait of Alan Turing...
Rising tensions with Iran push jet fuel costs higher, forcing freight operators to hedge, reroute, and stockpile. Thi...
Meta Platforms is weighing a bold move into prediction markets, boosting investor interest and triggering a rally. An...
A record M&A surge, pegged at roughly $4 trillion for 2026, is shaping the market. Wall Street is weighing whether a ...
A real-world look at why undisclosed stock trades in crypto can erode trust. This article uses a hypothetical scenari...
SpaceX blends rockets, satellites, and AI dreams. This piece examines whether could spacex eventually become the top ...